Effects of Eugenol on Nerve and Vascular Dysfunction in Streptozotocin-Diabetic Rats

Abstract

Hyperglycaemia in diabetes mellitus results in oxidative stress and pro-inflammatory changes which contribute to vascular complications including endothelial dysfunction and peripheral neuropathy. The aim of this study was to examine whether treatment with the dominant ingredient of clove oil, eugenol, which has antioxidant and anti-inflammatory properties, could improve diabetic vascular and nerve function in streptozotocin-induced diabetic rats. Intervention treatment was given for 2 weeks following 6 weeks of untreated diabetes. Dose-ranging studies on diabetic deficits in sciatic nerve motor and saphenous nerve sensory nerve conduction velocities gave ED₅₀ values of 28 mg/kg and 9 mg/kg, respectively, conduction velocity being within the non-diabetic range at a dose of 200 mg/kg. Sciatic nerve endoneurial blood flow was 49 % reduced by diabetes and this was completely corrected by 200 mg/kg eugenol treatment. Gastric fundus maximum nitrergic nerve-mediated relaxation was 44 % reduced by diabetes; eugenol corrected this deficit by 69 %. For renal artery rings, maximum endothelium-dependent relaxation to acetylcholine was 51 % reduced by diabetes; eugenol corrected this deficit by 60 %, with improvements in both nitric oxide and endothelium-derived hyperpolarising factor (EDHF)-mediated vasorelaxation components. Diabetes increased renal artery sensitivity to phenylephrine-mediated contraction, however, this was unaffected by eugenol treatment. Thus, aspects of both vascular and neural complications in experimental diabetes are improved by eugenol, which could have potential therapeutic implications for diabetic neuropathy and vasculopathy.

Key words

Eugenol - Syzygium aromaticum - diabetes - nerve conduction - pain - blood flow - gastric fundus - neuropathy - vascular endothelium - nitric oxide - EDHF - rat

References

• 1 Cameron N E, Eaton S EM, Cotter M A, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.  Diabetologia. 2001;  44 1973-88
• 2 Low P A. Diabetic autonomic neuropathy.  Semin Neurol. 1996;  16 143-51
• 3 Vinik A I, Maser R E, Mitchell B D, Freeman R. Diabetic autonomic neuropathy.  Diabetes Care. 2003;  26 1553-79
• 4 Jenkinson K M, Reid J J. Effects of diabetes on relaxations to non-adrenergic non-cholinergic nerve stimulation in longitudinal muscle of the rat gastric fundus.  Br J Pharmacol. 1995;  116 1551-6
• 5 Keegan A, Cotter M A, Cameron N E. Effect of diabetes and treatment with the antioxidant, α-lipoic acid, on endothelial and neurogenic responses on corpus cavernosum in rats.  Diabetologia. 1999;  42 343-50
• 6 Cellek S, Foxwell N A, Moncada S. Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats.  Diabetes. 2003;  52 2353-62
• 7 Gibson T M, Cotter M A, Cameron N E. Effects of α-lipoic acid on impaired gastric fundus innervation in diabetic rats.  Free Radic Biol Med. 2003;  35 160-8
• 8 Fujisawa S, Atsumi T, Kadoma Y, Sakagami H. Antioxidant and prooxidant action of eugenol-related compounds and their cytotoxicity.  Toxicology. 2002;  177 39-54
• 9 Chainy G B, Manna S K, Chaturvedi M M, Aggarwal B B. Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: effect on NF-kappaB, AP-1, JNK, MAPKK and apoptosis.  Oncogene. 2000;  19 2943-50
• 10 Kim S S, Oh O J, Min H Y, Park E J, Kim Y, Park H J. et al . Eugenol suppresses cyclooxygenase-2 expression in lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells.  Life Sci. 2003;  73 337-48
• 11 Damiani C EN, Rossoni L V, Vassallo D V. Vasorelaxant effects of eugenol on rat thoracic aorta.  Vascul Pharmacol. 2003;  40 59-66
• 12 Cameron N E, Cotter M A, Hohman T C. Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats.  Diabetologia. 1996;  39 172-82
• 13 Low P A, Lagerlund T D, McManis P G. Nerve blood flow and oxygen delivery in normal, diabetic and ischemic neuropathy.  Int Rev Neurobiol. 1989;  31 355-438
• 14 Cotter M A, Love A, Watt M J, Cameron N E, Dines K C. Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats.  Diabetologia. 1995;  38 1285-94
• 15 Priyadarsini K I, Guha S N, Rao M NA. Physico-chemical properties and antioxidant activities of methoxy phenols.  Free Radic Biol Med. 1998;  24 933-41
• 16 Rauscher F M, Sanders R A, Watkins J B. Effects of isoeugenol on oxidative stress pathways in normal and streptozotocin-induced diabetic rats.  J Biochem Mol Toxicol. 2001;  15 159-64
• 17 Kihara M, Schmelzer J D, Poduslo J F, Curran G L, Nickander K K, Low P A. Aminoguanidine effect on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals.  Proc Natl Acad Sci USA. 1991;  88 6107-11
• 18 Cameron N E, Cotter M A. Rapid reversal by aminoguanidine of the neurovascular effects of diabetes in rats: modulation by nitric oxide synthase inhibition.  Metabolism. 1996;  45 1147-52
• 19 Archibald V, Cotter M A, Keegan A, Cameron N E. Contraction and relaxation of aortas from diabetic rats: effects of chronic anti-oxidant and aminoguanidine treatments.  Naunyn Schmeidebergs Arch Pharmacol. 1996;  353 584-91
• 20 Bierhaus A, Haslbeck K M, Humpert P M, Liliensiek B, Dehmner T, Morcos M. et al . Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily.  J Clin Invest. 2004;  114 1741-51
• 21 Sagara M, Satoh J, Wada R, Yagihashi S, Takahashi K, Fukuzawa M. et al . Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine.  Diabetologia. 1996;  39 263-9
• 22 Cotter M A, Gibson T M, Cameron N E. Nuclear factor kappa B inhibition improves nerve function in diabetic rats.  Diabetologia. 2003;  46 Suppl 2 A70
• 23 Kamata K, Hosokawa M. Endothelial dysfunction in the perfused kidney from the streptozotocin-induced diabetic rat.  Res Commun Mol Pathol Pharmacol. 1997;  96 57-70
• 24 De Vriese A S, van de Voorde J, Blom H J, Vanhoutte P M, Verbeke M, Lameire N H. The impaired renal vasodilator response attributed to endothelium-derived hyperpolarizing factor in streptozotocin-induced diabetic rats is restored by 5-methyltetrahydrofolate.  Diabetologia. 2000;  43 1116-25
• 25 Keegan A, Jack A M, Cameron N E, Cotter M A. Effects of aldose reductase inhibition on responses of the corpus cavernosum and mesenteric vascular bed of diabetic rats.  J Cardiovasc Pharmacol. 2000;  35 606-13
• 26 Nangle M R, Cotter M A, Cameron N E. Effects of rosuvastatin on nitric oxide-dependent function in aorta and corpus cavernosum of diabetic mice: relationship to cholesterol biosynthesis pathway inhibition and lipid lowering.  Diabetes. 2003;  52 2396-402
• 27 Criddle D N, Madeira S VF, de Moura R S. Endothelium-dependent and -independent vasodilator effects of eugenol in the rat mesenteric vascular bed.  J Pharm Pharmacol. 2003;  55 359-65
• 28 Lahlou S, Interaminense L FL, Magalhaes P JC, Leal-Cardoso J H, Duarte G P. Cardiovascular effects of eugenol, a phenolic compound present in many plant essential oils, in normotensive rats.  J Cardiovasc Pharmacol. 2004;  43 250-7
• 29 Fujii K, Heistad D D, Faraci F M. Effects of diabetes mellitus on flow mediated and endothelium-dependent dilation of the rat basilar artery.  Stroke. 1992;  23 1494-8
• 30 Cameron N E, Cotter M A. Diabetes causes an early reduction in autonomic ganglion blood flow in rats.  J Diabet Complications. 2001;  15 198-202